A, Relative Sln gene expression level in soleus and extensor digitorum longus (EDL) muscle. Data are means ± SEM, n = 7 mice/group. P values of treatment factor was analysed by Mixed-effects model (REML, two-sided without adjustment). B, Relative expression level of Atp2a1, Atp2a2, Ucp3, Sln, Pln, Ppard, Gpd2, Cox8b and Pppargc1a in TA muscle from beta-less mice. n = 6 mice/group. C, Relative expression level of Atp2a1, Atp2a2, Sln, Pln, Gpd2, and Cpt1a in myotubes treated with vehicle, GDF15 and norepinephrine (NE). n = 7 biologically independent samples/group. P values by two-way ANOVA with Tukey’s multiple comparisons test. D, Sln expression in quadriceps isolated from mice treated with the vehicle or beta-2 agonist (Clenbuterol). Data are means ± SEM, n = 10 mice/group. P values by unpaired t test (two-sided). E, Representative immunohistochemical staining for fibre types in gastrocnemius. F, Muscle fibre type percentage. Data are mean ± SEM, n = 4 group. G, Representative images of frozen gastrocnemius muscle sections stained with H&E (4 mice/group). Within each gastrocnemius, the entire muscle cross-section was visualized and imaged to evaluate the whole cross-section in its entirety. H, Absolute mitochondrial respiration (JO2); S4: State 4 (pyruvate + malate), S2: State 2 (pyruvate + malate, depleted ADP), S3: State 3 (PMD (+max ADP)), CI: maximal CI respiration (PMDG (+max glutamate)), CII: maximal CII respiration (+max succinate), RCR: S3/S4. Data are means ± SEM, n = 6 mice/group. I, Representative trace of oxygen depletion in mitochondria in the presence of 100 μM (200 nmoles) ADP for determination of ADP/O ratios. Data are means ± SEM, n = 6 mice/group. J, Absolute mitochondrial JO2 with oligomycin and maximal CII supported respiration. OMY: JO2 with mitochondria + oligomycin (no substrates), CII: maximal respiration with PMDGS. Data are means ± SEM, n = 6 mice/group. K, Change in mitochondrial JO2 from OMY with PMDGS. Data are means ± SEM, n = 6 mice/group. P values by one-way ANOVA with Tukey’s multiple comparisons test. L, JO2 in permeabilized fibres in the presence and absence of ADP and various substrates. Data are means ± SEM, n = 5 mice/group except GDF15 group, n = 6 mice. M, Oxygen consumption (JO2) in permeabilized muscle fibres treated with (PM, Pyruvate + Malate, ATP, Ca2+ or CPA, cyclopiazonic acid). Data are means ± SEM, n = 6 mice/group except GDF15 group, n = 5 mice. P values by two-way ANOVA with Šídák’s multiple comparisons test. N, Change in JO2 during a calcium titration in permeabilized fibres. Data are means ± SEM, n = 6 mice/group except GDF15 group, n = 5 mice. P values by two-way ANOVA with Tukey’s multiple comparisons test. P- pyruvate; M - malate; D - ADP; G - glutamate; S - succinate; RCR - respiratory control ratio. O, Absolute JO2. Data are means ± SEM, n = 8 mice/group. P values by unpaired t test (two-sided).
Source data